Tyrosinase mutants are capable of prodrug activation in transfected nonmelanotic cells

Cancer Research

Volumn 60, Issue 23, 2000, Pages 6656-6662

  Simonova, M ^a   Wall, A ^a   Weissleder, R ^a   Bogdanov A , Jr ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELANIN; MONOPHENOL MONOOXYGENASE; PHENOL DERIVATIVE; PRODRUG; PROPANOL;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG ACTIVATION; ENZYME ACTIVITY; FIBROSARCOMA; GENE THERAPY; GENETIC TRANSFECTION; GLIOSARCOMA; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; BIOTRANSFORMATION; CELL DIVISION; CELL LINE; CYSTEAMINE; FIBROSARCOMA; GLIOSARCOMA; HUMANS; KIDNEY; MELANINS; MONOPHENOL MONOOXYGENASE; MUTATION; PHENOLS; PRODRUGS; PROPANOLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034541169     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. The choice of prodrugs for gene directed enzyme prodrug therapy of cancer
2. Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954
3. A first step in the development of gene therapy for colorectal carcinoma: Cloning, sequencing, and expression of Escherichia coli cytosine
4. In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene
5. Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies
6. Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway
7. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: Results of a Phase I clinical trial in malignant mesothelioma
8. Intensely cytotoxic anthracycline prodrugs: Glucuronides
9. Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastases
10. In vivo and in vitro glioma cell killing induced by an adenovirus expressing both cytosine deaminase and thymidine kinase and its association with interferon-α
11. Adenoviral-mediated transfer of a heat-inducible double suicide gene into prostate carcinoma cells
12. Hydroxyanisole-induced regression of the Harding-Passey melanoma in mice
13. Selective toxicity of 6-hydroxydopa for melanoma cells
14. The in vivo melanocytotoxicity and depigmenting potency of N-2,4-acetoxyphenyl thioethyl acetamide in the skin and hair
15. N-acetyl-4-S-cysteaminylphenol as a new type of depigmenting agent for the melanoderma of patients with melasma
16. Tyrosinase transfection produces melanin synthesis and growth retardation in glioma cells
17. Promotion of tyrosinase folding in COS 7 cells by calnexin
18. Tyrosinase: A comprehensive review of its mechanism
19. Cotransfection of genes encoding human tyrosinase and tyrosinase-related protein-1 prevents melanocyte death and enhances melanin pigmentation and gene expression of Lamp-1
20. Incomplete expression of the tyrosinase gene family (tyrosinase, TRP-1, and TRP-2) in human malignant melanoma cells in vitro
21. Melanogenesis-targeted antimelanoma pro-drug development: Effect of side-chain variations on the cytotoxicity of tyrosinase-generated ortho-quinones in a model screening system
22. Thymidylate synthase as a target enzyme for the melanoma-specific toxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol
23. Intracellular sorting and targeting of melanosomal membrane proteins: Identification of signals for sorting of the human brown locus protein, gp75
24. Sorting and secretion of a melanosome membrane protein, gp75/TRP1
25. The cytoplasmic tail of the mouse brown locus product determines intracellular stability and export from the endoplasmic reticulum
26. Tyrosinase folding and copper loading in vivo: A crucial role for calnexin and α-glucosidase II
27. Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA
28. Pigmentation genes: The tyrosinase gene family and the pmel 17 gene family
29. Misrouting of tyrosinase with a truncated cytoplasmic tail as a result of the murine platinum (cp) mutation
30. Isolation and sequencing of a cDNA clone encoding lysosomal membrane glycoprotein mouse LAMP-1
31. Analogs of synthetic melanin polymers for specific imaging applications
32. An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs
33. Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells
34. Factors influencing the survival of rat brain tumor cells after in vitro treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea
35. L-tyrosine-3,5-3H assay for tyrosinase development in skin of newborn hamsters
36. Regulation of melanogenesis in B16 mouse melanoma cells by protein kinase C
37. Regulation of tyrosinase in human melanocytes grown in culture
38. Paramagnetic metal scavenging by melanin: MR imaging
39. Immunotyping of melanomas for tyrosinase: Implications for vaccine development
40. Antihypertensive activities of phenylaminoethyl sulfides, a class of synthetic substrates for dopamine β-hydroxylase
41. Effects of tyrosinase activity on the cytotoxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol in melanoma cells
42. In vitro studies of 2,4-dihydroxyphenylalanine, a prodrug targeted against malignant melanoma cells
43. Melanocytotoxicity and antimelanoma effects of phenolic amine compounds in mice in vivo
44. Synthesis and antimelanoma effect of the melanogenesis-based antimelanoma agent N-propionyl-4-S-cysteaminylphenol
45. Pigment content of cultured human melanocytes does not correlate with tyrosinase message level
46. Characterization of a melanosomal transport system in murine melanocytes mediating entry of the melanogenic substrate tyrosine
47. The melanoma antigen gp 75 is the human homologue of the mouse b (brown) locus gene product
48. Selective transfer of a lipophilic prodrug of 5-fluoro-deoxyuridine from immunoliposomes to colon cancer cells